When breast cancer was divided into BMAL1 and LDH-A low or high groups by the mean median value, recurrence free survival (RFS) was higher in the BMAL1 high group than the BMAL1 low group and lower in the LDH-A high group than the LDH-A low group (Figure 6c,d). This evidence concerns the gene BMAL1 and breast cancer.